News

uMotif attending Partnerships in Clinical Trials Europe Conference in Barcelona
‘Real-World Evidence Mythbusting’ in Clinical Trials Innovation
An Unforgettable First SCDM Experience in Seattle
uMotif nominated for OBN award
uMotif secures £2.4 million funding – led by Albion Capital
uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board
uMotif attending SCDM 2018 Annual Conference in Seattle
Guardian Article: The app that could save lives by speeding up drug trials
Our employee interview series continues with a technology focus